The pre-approval inspection took place over four days for an API that the Malvern, PA site will manufacture for a global ...
AbbVie is investing $380 million to build two new active pharmaceutical ingredient (API) manufacturing facilities at its ...
Learn why Water for Injection (WFI) is a strategic utility in sterile drug manufacturing and how outsourcing WFI production ...
Merck, known as MSD outside the U.S. and Canada, is restructuring its Human Health organization and appointing three new ...
Akums Drugs & Pharmaceuticals Ltd., India's largest CDMO, has secured European Union Good Manufacturing Practice ...
Bora Pharmaceuticals and GSK are renewing a five-year manufacturing partnership with the signing of a new strategic agreement.
Gilead Sciences Inc. has agreed to acquire Arcellx, a biotechnology company, for an implied equity value of $7.8 billion.
The FDA has approved AstraZeneca’s Calquence (acalabrutinib) for adults with chronic lymphocytic leukemia and small ...
Pluri Inc.’s subsidiary, Pluri Biotech, has been granted a patent by the China National Intellectual Property Administration ...
Thermo Fisher Scientific has introduced a laboratory kit designed to extract protein, DNA and RNA from a single biological ...
Following a prior Refusal-to-File and Type A meeting, the FDA's CBER will proceed to review BLA for mRNA-1010.
RoukenBio and AVS Bio have formed a strategic partnership aimed at streamlining the development of therapeutic antibodies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results